Publications by authors named "Michael Maker"

Claim this Profile
R
Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study.
Marie Burstedt, James H Whelan, Jane S Green, Karen Holopigian, Claudio Spera, Michael Maker

Invest Ophthalmol Vis Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Celiac Disease Severity Using Video Capsule Endoscopy: A Comparison of Human Experts and Machine Learning Algorithms.
Stefania Chetcuti Zammit, Mark E McAlindon, Elliot Greenblatt, Michael Maker, Jenifer Siegelman

Curr Med Imaging· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive molecular tracking method that measures ocular drug distribution in non-human primates.
Guillaume Normand, Michael Maker, Jan Penraat, Kellyann Kovach, Joy G Ghosh

Commun Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
Adrian Will-Orrego, Yubin Qiu, Elizabeth S Fassbender, Siyuan Shen, Jorge Aranda, Michael Maker

J Ocul Pharmacol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting protein drugs for the treatment of ocular diseases.
Joy G Ghosh, Andrew A Nguyen, Chad E Bigelow, Stephen Poor, Yubin Qiu, Michael Maker

Nat Commun· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice.
Vivian W Choi, Chad E Bigelow, Terri L McGee, Akshata N Gujar, Hui Li, Michael Maker

Mol Ther Methods Clin Dev· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis